🇺🇸 FDA
Patent

US 11708410

Antibodies and variants thereof against TIGIT

granted A61KA61K2039/505A61K39/39541

Quick answer

US patent 11708410 (Antibodies and variants thereof against TIGIT) held by Nanjing Legend Biotech Co., Ltd expires Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nanjing Legend Biotech Co., Ltd
Grant date
Tue Jul 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61K39/39541, A61K45/06, A61P